Figure 2.

The estimated SDS total scores during follow-up by treatment cohorts in patients with and without PPS at baseline.

Notes: P=0.546 for the difference in SDS total scores between the two treatment cohorts at baseline and P<0.001 at 24 weeks in the subgroup of PPS+ patients. P=0.013 at baseline and P=0.168 at 24 weeks in the subgroup of PPS− patients. *The baseline scores are raw mean values.

Abbreviations: SDS, Sheehan Disability Scale; PPS, painful physical symptoms; SSRI, selective serotonin reuptake inhibitor.